Home > M&A deals 2018 > Ferring International Center S.A (Ferring Pharmaceuticals) acquires Rebiotix, Inc.
Add-on Acquistion · Life Science · April 2018

Ferring International Center S.A (Ferring Pharmaceuticals) acquires Rebiotix, Inc.

On April 5, 2018, Ferring International Center S.A (Ferring Pharmaceuticals) acquired Rebiotix, Inc., a life science company in Minnesota, United States.

Deal at a glance

AnnouncedApril 5, 2018 TypeAdd-on Acquistion TargetRebiotix, Inc. Buyer Ferring International Center S.A (Ferring Pharmaceuticals) SectorLife Science LocationMinnesota, United States ValueNot disclosed

Target company

Rebiotix, Inc.
Minnesota, United States
Life Sciencesector
-founded
Activestatus
View the company profile →

Buyer

Ferring International Center S.A (Ferring Pharmaceuticals)
Company · 1 deal on record
  • 1st transaction in life science
  • 1st transaction in United States
1deals, all time
1in this sector
2018latest

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

Orbus Therapeutics, Inc.Same sector and country · Oct 2026
ArtesRx LLCSame sector and country · Aug 2026
Firefly Bio, Inc.Same sector and country · Jul 2026

Questions about this deal

Who acquired Rebiotix, Inc.?Ferring International Center S.A (Ferring Pharmaceuticals) acquired Rebiotix, Inc. on April 5, 2018.

What type of deal was it?It was a add-on acquistion in the life science sector in 2018.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).